1. Psychotropic Medication Use in French Children and Adolescents
- Author
-
Emmanuelle Leray, Viviane Kovess, Mathilde M. Husky, Sabine Choppin, Mathilde Pivette, Fei Gao, Département Epidemiologie et Biostatistiques, Université Paris Descartes - Paris 5 (UPD5)-École des Hautes Études en Santé Publique [EHESP] (EHESP), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), École des Hautes Études en Santé Publique [EHESP] (EHESP), Recherche en Pharmaco-épidémiologie et Recours aux Soins (REPERES), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP), Université Paris Descartes - Paris 5 ( UPD5 ) -École des Hautes Études en Santé Publique [EHESP] ( EHESP ), Ecole des hautes études en santé publique, Centre d'Investigation Clinique [Rennes] ( CIC ), Université de Rennes 1 ( UR1 ), and Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale ( INSERM )
- Subjects
Male ,Drug ,medicine.medical_specialty ,Adolescent ,Databases, Factual ,media_common.quotation_subject ,Population ,MEDLINE ,Psychotropic medication ,Age and gender ,[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathology ,Humans ,Medicine ,Pharmacology (medical) ,Medical prescription ,Child ,Psychiatry ,education ,media_common ,Psychotropic Drugs ,education.field_of_study ,business.industry ,Mental Disorders ,[SCCO.NEUR]Cognitive science/Neuroscience ,Infant, Newborn ,Infant ,3. Good health ,Psychiatry and Mental health ,National health insurance ,Psychotropic drug use ,Child, Preschool ,Family medicine ,[ SCCO.NEUR ] Cognitive science/Neuroscience ,Pediatrics, Perinatology and Child Health ,Female ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,France ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
International audience; OBJECTIVE: The purpose of this study was to describe the patterns of psychotropic drug use in a large representative population of children and adolescents drawn from the French National Health Insurance databank. METHODS: Data were drawn from a sample of 1% of the beneficiaries of the French national health insurance, selecting those 0-17 years old in 2010 (n=128,298). In addition to age and gender, data included the identification number of each drug allowing a European Pharmaceutical Marketing Research Association (EphMRA) classification, as well as the type of the prescriber. RESULTS: Overall, 2.5% of children and adolescents had been prescribed psychotropic medication. A majority were prescribed anxiolytics (1.9%), followed by antidepressants (0.3%), antipsychotics (0.3%), and stimulants (0.2%). Between the ages of 15 and 17, 6.1% of girls were prescribed anxiolytics and 1.1% were prescribed antidepressants. For boys, the anxiolytics remained the most prescribed psychotropic medication; however, between the ages of 11 and 14, and between the ages of 15 and 17 they received more antipsychotics (0.7% and 0.8%) and between the ages of 6 and 10, and between the ages of 11 and 14 (0.7% and 0.6%), they were prescribed more stimulants than were girls. Among those who received a prescription, a majority of youth (84.6%) received only one class of drugs, and general practitioners were found to be prescribing most of these prescriptions (81.7%). CONCLUSIONS: The prevalence of psychotropic drug use in France is similar to that of the Netherlands and much lower than what is observed in the United States. Stimulants are less frequently prescribed in France than in other European countries, but anxiolytics are prescribed considerably more in France than in any other country.
- Published
- 2015
- Full Text
- View/download PDF